MKM Starts BioSpecifics Technologies (BSTC) at Buy, Sets $26.50 Target
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
MKM Partners initiated coverage on BioSpecifics Technologies (NASDAQ: BSTC) with a Buy rating and a $26.50 price target.
For an analyst ratings summary and ratings history on BioSpecifics Technologies click here. For more ratings news on BioSpecifics Technologies click here.
Shares of BioSpecifics Technologies closed at $15.92 Wednesday.
For an analyst ratings summary and ratings history on BioSpecifics Technologies click here. For more ratings news on BioSpecifics Technologies click here.
Shares of BioSpecifics Technologies closed at $15.92 Wednesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Keefe, Bruyette & Woods Resumes Bank of Nova Scotia (BNS:CN) (BNS) at Outperform
- TD Cowen Assumes Janux Therapeutics (JANX) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
